CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review Nitrosative stress drives heart failure with preserved ejection fraction Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead? Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure Heart Failure With Preserved Ejection Fraction in the Young HFpEF: From Mechanisms to Therapies Functional Impairment and Medication Burden in Adults With Heart Failure

Clinical Trial2017 Aug 22;318(8):713-720.

JOURNAL:JAMA. Article Link

Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

Felker GM, Anstrom KJ1, Adams KF et al. Keywords: Natriuretic Peptide–Guided Therapy; RCT; usual care; Hospitalization; Cardiovascular Mortality ; Heart Failure and Reduced Ejection Fraction

FULL TEXT PDF